IL152075A0 - Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) - Google Patents

Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Info

Publication number
IL152075A0
IL152075A0 IL15207501A IL15207501A IL152075A0 IL 152075 A0 IL152075 A0 IL 152075A0 IL 15207501 A IL15207501 A IL 15207501A IL 15207501 A IL15207501 A IL 15207501A IL 152075 A0 IL152075 A0 IL 152075A0
Authority
IL
Israel
Prior art keywords
nhe
inhibitor
sodium
exchanger type
hydrogen exchanger
Prior art date
Application number
IL15207501A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL152075A0 publication Critical patent/IL152075A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15207501A 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) IL152075A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IL152075A0 true IL152075A0 (en) 2003-05-29

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15207501A IL152075A0 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (cs)
JP (1) JP2003531900A (cs)
KR (1) KR20020093079A (cs)
CN (1) CN1225466C (cs)
AP (1) AP2002002651A0 (cs)
AR (1) AR028375A1 (cs)
AU (1) AU2001235896A1 (cs)
BG (1) BG107139A (cs)
BR (1) BR0110268A (cs)
CA (1) CA2407535A1 (cs)
CO (1) CO5221125A1 (cs)
CR (1) CR6797A (cs)
CZ (1) CZ20023408A3 (cs)
DZ (1) DZ3310A1 (cs)
EA (1) EA004882B1 (cs)
EE (1) EE200200615A (cs)
GT (1) GT200100064A (cs)
HN (1) HN2001000042A (cs)
HR (1) HRP20020851A2 (cs)
HU (1) HUP0300651A2 (cs)
IL (1) IL152075A0 (cs)
IS (2) IS6567A (cs)
MA (1) MA26897A1 (cs)
MX (1) MXPA02010600A (cs)
MY (1) MY133842A (cs)
NO (1) NO20025132L (cs)
NZ (1) NZ521348A (cs)
OA (1) OA12256A (cs)
PA (1) PA8513301A1 (cs)
PE (1) PE20011270A1 (cs)
PL (1) PL357765A1 (cs)
SK (1) SK14872002A3 (cs)
SV (1) SV2002000418A (cs)
TN (1) TNSN01065A1 (cs)
TR (1) TR200202439T2 (cs)
UA (1) UA73348C2 (cs)
UY (1) UY26680A1 (cs)
WO (1) WO2001083470A1 (cs)
YU (1) YU79602A (cs)
ZA (1) ZA200208605B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20032017A3 (cs) * 2001-01-31 2004-05-12 Pfizeráproductsáinc Ethanoláty inhibitoru sodík@vodík měniče typu �Ź způsob jejich přípravyŹ jejich použití a farmaceutický prostředekŹ který je obsahuje
WO2003051845A1 (en) * 2001-12-19 2003-06-26 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
AU2003219421A1 (en) * 2002-05-02 2003-11-17 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
EP1596860A4 (en) * 2003-02-14 2009-05-27 Smithkline Beecham Corp NEW CONNECTIONS
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003603B1 (ru) * 1998-02-27 2003-06-26 Пфайзер Продактс Инк. N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии

Also Published As

Publication number Publication date
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
NO20025132L (no) 2002-12-12
BR0110268A (pt) 2003-12-30
WO2001083470A1 (en) 2001-11-08
SV2002000418A (es) 2002-07-03
UA73348C2 (en) 2005-07-15
EP1276737A1 (en) 2003-01-22
DZ3310A1 (fr) 2001-11-07
NZ521348A (en) 2004-09-24
CN1426404A (zh) 2003-06-25
SK14872002A3 (sk) 2004-03-02
CN1225466C (zh) 2005-11-02
EE200200615A (et) 2004-04-15
ZA200208605B (en) 2003-10-24
UY26680A1 (es) 2001-12-28
HN2001000042A (es) 2001-07-09
JP2003531900A (ja) 2003-10-28
KR20020093079A (ko) 2002-12-12
PE20011270A1 (es) 2001-12-12
NO20025132D0 (no) 2002-10-25
GT200100064A (es) 2002-03-22
PA8513301A1 (es) 2003-09-05
IS6588A (is) 2002-10-21
MY133842A (en) 2007-11-30
PL357765A1 (en) 2004-07-26
TNSN01065A1 (fr) 2005-11-10
CZ20023408A3 (cs) 2004-01-14
CR6797A (es) 2004-05-17
AP2002002651A0 (en) 2002-12-31
HUP0300651A2 (hu) 2003-07-28
HRP20020851A2 (en) 2005-02-28
OA12256A (en) 2003-11-06
MXPA02010600A (es) 2003-03-10
AU2001235896A1 (en) 2001-11-12
BG107139A (bg) 2003-07-31
EA200201023A1 (ru) 2003-02-27
AR028375A1 (es) 2003-05-07
CA2407535A1 (en) 2001-11-08
CO5221125A1 (es) 2002-11-28
TR200202439T2 (tr) 2003-02-21
IS6567A (is) 2002-09-24
EA004882B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
PL349872A1 (en) Heat exchanger
EP1347260A4 (en) HEAT EXCHANGER
EP1347259A4 (en) Heat Exchanger
EP1249586A4 (en) Heat Exchanger
EP1306156A4 (en) THERMAL DIVERS
DZ3310A1 (fr) Inhibiteurs de l'echangeur sodium-hydrogene de type 1
GB2367355B (en) A heat exchanger
ZA200203295B (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
GB0031183D0 (en) Heat exchanger
HK1036057A1 (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor
GB2367886B (en) Heat exchanger
GB0009380D0 (en) Heat exchanger
GB0111114D0 (en) Heat exchanger
GB0011633D0 (en) Heat exchangers
GB0026297D0 (en) Heat exchangers
GB0004817D0 (en) Heat exchanger
GB0030201D0 (en) Heat exchanger
GB0006080D0 (en) Heat exchanger
GB0009182D0 (en) Heat exchanger
GB0013054D0 (en) Heat exchanger
GB0021098D0 (en) Heat exchanger
PL340103A1 (en) Heat exchanger
TW454907U (en) Twin-layer cooling board
GB0029160D0 (en) Drop down radiator Mk 4
GB0014058D0 (en) Improved heat exchanger